Obsessive-compulsive disorder modern options mature
Deep brain stimulation maturity, novel glutamate-modulator programs, and refined transcranial magnetic stimulation protocols are reshaping refractory OCD management.
Obsessive-compulsive disorder has been an SSRI-and-clomipramine pharmacotherapy category with augmentation strategies for years. Deep brain stimulation has approval for refractory OCD and growing real-world data. Novel glutamate-modulator programs (including troriluzole and others), refined transcranial magnetic stimulation protocols, and emerging psychedelic-assisted therapy programs are reshaping refractory OCD management. The infrastructure question (specialist OCD-care availability) is the addressable-population enabler.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.